REGN  valuation analysis

Name: Regeneron Pharmaceuticals Inc
Description: Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 04, 2022
Market cap: $78.14B (97th)
Sales(TTM): $16.51B (203rd)
Earnings(TTM): $7.93B (51st)

FFER: 0.49*
Actual price: $690.88
* Earnings were reported Aug 03, 2022 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
  • Regeneron Pharmaceuticals Inc's sales grew by 79.5% ($9.20B to $16.51B) over one year against a market average growth of 29.0%.
Earnings / MarketCap
Regeneron Pharmaceuticals Inc
"Biotechnology" industry
Sales / MarketCap
Regeneron Pharmaceuticals Inc
"Biotechnology" industry
Book / MarketCap
Regeneron Pharmaceuticals Inc
"Biotechnology" industry
Equity / Assets
Regeneron Pharmaceuticals Inc
"Biotechnology" industry